Plus, some thoughts about Transcarent buying Accolade!
Because so many of you asked for it!
Things have gotten a little better in digital health VC land, but it’s still challenging out there!
How I’ve been thinking about recent events
Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto
I teamed up with two health policy experts to explore the bull and bear case.
The company closed up shop abruptly this week.
Lessons learned after a strategy shift featuring Brightline CEO Naomi Allen and investor Alyssa Jaffee
That’s the question of the moment - and we explore it in-depth.
With Tom Cassels, who’s sat on plenty of boards as an independent director
I’m introducing a new series to ask experts in the space tough questions about topics of the moment
One longtime women's health investor weighs in...
